Results 171 to 180 of about 409,120 (302)

Predicting sudden cardiac death in heart failure with reduced ejection fraction. [PDF]

Heart Fail Rev
Mkrtchyan N, Akram A, Dixit N, Hajduczok A, Birs A.   +4 more
europepmc   +1 more source

Incidence of Childhood Dilated Cardiomyopathy in Sweden From 1991 to 2019: A National Population‐Based Study

Acta Paediatrica, EarlyView.
ABSTRACT Aim To study the incidence, survival, and mortality of dilated cardiomyopathy (DCM) in children in Sweden, 1991–2019. Methods Hospital records of 0–18‐year‐olds diagnosed with DCM over a 29‐year period were reviewed. The annual sex‐specific incidence rates of DCM were calculated as new disease cases, divided by the average Swedish same‐sex ...
Shalan Fadl, Stefan Särnblad, Tahir Taj, Håkan Wåhlander, Eva Fernlund, Jan Sunnegårdh   +5 more
wiley   +1 more source

Sudden cardiac death secondary to acute aortic syndromes in young athletes in the United States. [PDF]

Eur J Prev Cardiol
Petek BJ, Moulson N, Baggish AL, Kliethermes SA, Maleszewski JJ, Delong R, Kucera KL, Harmon KG, Drezner JA, Churchill TW.   +9 more
europepmc   +1 more source

Non‐Alzheimer Aβ deposits in the human CNS: Implications with hypoxia and related conditions

Brain Pathology, EarlyView.
An Aβ deposit in a non‐Alzheimer's brain from an individual who experienced hypoxia/energy failure. Abstract We recently reported the deposition of Aβ in the frontal cortex of individuals who died of acute coronavirus disease 2019 (COVID‐19), or who did not have COVID‐19 but had respiratory distress, or infants with severe cardiac malformations.
Esma Karlovich, David S. Priemer, Charles Harker Rhodes, Daniel P. Perl, Kurenai Tanji, James E. Goldman   +5 more
wiley   +1 more source

Rassi Score for Secondary Prevention of Sudden Cardiac Death in Chagas Heart Disease. [PDF]

Am J Trop Med Hyg
Veloso HH, Hasslocher-Moreno AM, Saraiva RM.   +2 more
europepmc   +1 more source

The Future of Sudden Cardiac Death [PDF]

Annals of Noninvasive Electrocardiology, 2009
openaire   +2 more sources

Refining the treatment of immune checkpoint inhibitor–associated myocarditis: Challenges, innovations and rechallenge considerations

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitor (ICI)‐associated myocarditis has emerged as a severe and clinically complex immune‐related toxicity that poses significant challenges for therapeutic decision‐making in routine cardio‐oncological care. High‐dose corticosteroids remain the first‐line therapy, yet their timing, dosage and tapering require careful clinical ...
Raluca I. Mincu, Lisa Zimmer, Dimitra Vlachopoulou, Elias Haj‐Yehia, Julia Hoffmann, Lars Michel, Elisabeth Livingstone, Dirk Schadendorf, Alpaslan Tasdogan, Matthias Totzeck, Tienush Rassaf   +10 more
wiley   +1 more source

Identification of a plasma proteomic signature associated with sudden cardiac death risk in the UK biobank. [PDF]

Front Cardiovasc Med
Dai S, Wu M, Zheng L, Chen Y, Huang S, Hao J, Liu F, He X, Long G, Zou Y, Xu C.   +10 more
europepmc   +1 more source

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).

European Heart Journal, 2014
C. O’Mahony, F. Jichi, M. Pavlou, L. Monserrat, A. Anastasakis, C. Rapezzi, E. Biagini, J. Gimeno, G. Limongelli, W. McKenna, R. Omar, P. Elliott   +11 more
semanticscholar   +1 more source

Immune checkpoint inhibitor‐induced arrhythmias: Mechanistic insights from clinical and preclinical studies

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, but their efficacy continues to be limited by immune‐related adverse events. Among these, ICI‐induced cardiac arrhythmias are increasingly recognised as a major adverse reaction, encompassing a broad spectrum of clinical phenotypes, including conduction blocks, atrial fibrillation and
Anand R. Ramalingam, Zoltán Márton Köhler, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source